CORE--BIOTECHNOLOGY FACILITY

$0P30FY2001CANIH

Northwestern University, Evanston IL

Investigators

Linked publications & trials

Paper 39711568 Paper 39639015 Paper 39622796 Paper 39605341 Paper 39602541 Paper 39554163 Paper 39484464 Paper 39470208 Paper 39427160 Paper 39388266 Paper 39375363 Paper 39367123 Paper 39345456 Paper 39331023 Paper 39314294 Paper 39293067 Paper 39282345 Paper 39273043 Paper 39229171 Paper 39229068 Paper 39219219 Paper 39207859 Paper 39207852 Paper 39188380 Paper 39175771 Paper 39173639 Paper 39162011 Paper 39153592 Paper 39138384 Paper 39137400 Paper 39137048 Paper 39129772 Paper 39128135 Paper 39106310 Paper 39097611 Paper 39025452 Paper 38987586 Paper 38979191 Paper 38965984 Paper 38965227 Paper 38947010 Paper 38906115 Paper 38895336 Paper 38888996 Paper 38874796 Paper 38870058 Paper 38861595 Paper 38853981 Paper 38853959 Paper 38844770 Paper 38781029 Paper 38773124 Paper 38766251 Paper 38761794 Paper 38755144 Paper 38746232 Paper 38722697 Paper 38701221 Paper 38694428 Paper 38684051 Paper 38662454 Paper 38659828 Paper 38645111 Paper 38631711 Paper 38606301 Paper 38597153 Paper 38575093 Paper 38539515 Paper 38537641 Paper 38530357 Paper 38519987 Paper 38507238 Paper 38502186 Paper 38497708 Paper 38496411 Paper 38486049 Paper 38485094 Paper 38458998 Paper 38453366 Paper 38450218 Paper 38446806 Paper 38443336 Paper 38441967 Paper 38431907 Paper 38431639 Paper 38386777 Paper 38378783 Paper 38358348 Paper 38355731 Paper 38350724 Paper 38346948 Paper 38344207 Paper 38341851 Paper 38337096 Paper 38331132 Paper 38329810 Paper 38313292 Paper 38301954 Paper 38295144 Paper 38280846

Abstract

DESCRIPTION (provided by applicant): The Northwestern University Biotechnology Laboratory (NUBL) provides Cancer Center investigators access to the latest technologies in genomics and proteomics. Specifically, the NUBL provides centralized services to members of Viral Oncogenesis, Tumor Invasion, Metastasis and Angiogenesis, Hormone Action and Signal Transduction in Cancer, Cancer Genes and Molecular Regulation, Breast Oncology, Prostate Cancer, Hematologic Malignancies, Pediatric Oncology and Cancer Prevention. This facility has a newly appointed director, Dr. Victor Levenson, who is an accomplished molecular biologist. An Advisory Committee oversees operation of NUBL and sets operating priorities. Services currently offered include: DNA purification and DNA sequencing, 2-D protein gel electrophoresis, phosphorimager for quantitation of radioactive gels and HPLC analysis of nucleic acids and proteins. In addition, NUBL provides training and education programs to introduce scientists to novel technologies and new instrumentation. The NUBL is in the process of implementing macro- and microarray based technologies for comparative analysis of gene expression, biorobot for automated DNA isolation, and mass spectrometers for analysis of biological macromolecules. The NUBL will also provide post-genomic services: functional proteomics (yeast two-hybrid screens and protein chip assays) as well as structural genomics, proteomics and drug design (in coordination with the Structural Biology Facility, Keck Biophysics Facility and the Analytical Services Laboratory). The NUBL provides, coordinates and develops high quality services to Cancer Center members at competitive prices, increasing the availability of modern technologies to Cancer Center investigators.

View original record on NIH RePORTER →